MORGAN STANLEY

Holdings History for Design Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DSGN)

Symbol: DSGN on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$6,587,630	702,306	+526,315	+299%	$9.38	Q4 2025
30 Sep 2025	0%	-0%	$1,325,213	175,991	-37,559	-18%	$7.53	Q3 2025
30 Jun 2025	0%	-0%	$719,663	213,550	-34,328	-14%	$3.37	Q2 2025
31 Mar 2025	0%	-0%	$956,808	247,878	-98,305		$3.86	Q1 2025
31 Dec 2024	0%	-0%	$2,135,950	346,183	-82,615		$6.17	Q4 2024
30 Sep 2024	0%	+0%	$2,306,932	428,798	+39,361		$5.38	Q3 2024
30 Jun 2024	0%	-0%	$1,304,613	389,437	-88,655		$3.35	Q2 2024
31 Mar 2024	0%	-0%	$1,926,712	478,092	-65,389	-12%	$4.03	Q1 2024
31 Dec 2023	0%	+0%	$1,440,226	543,481	+183,223	+51%	$2.65	Q4 2023
30 Sep 2023	0%	+0%	$850,208	360,258	+169,490	+89%	$2.36	Q3 2023
30 Jun 2023	0%	+0%	$1,201,839	190,768	+121,391	+175%	$6.30	Q2 2023
31 Mar 2023	0%	+0%	$400,305	69,377	+27,953	+67%	$5.77	Q1 2023
31 Dec 2022	0%	-0%	$425,010	41,424	-17,491	-30%	$10.26	Q4 2022
30 Sep 2022	0%	+0%	$985,000	58,915	+20,132	+52%	$16.72	Q3 2022
30 Jun 2022		0%	$1,000	49	0		$20.41 ^*	Q2 2022
30 Jun 2022	0%	+0%	$543,000	38,783	+25,967	+203%	$14.00	Q2 2022
31 Mar 2022	0%	-0%	$207,000	12,816	-466	-3.5%	$16.15	Q1 2022
31 Dec 2021	0%	+0%	$285,000	13,282	+5,892	+80%	$21.46	Q4 2021
30 Sep 2021	0%	+0%	$108,000	7,390	+6,743	+1042%	$14.61	Q3 2021
30 Jun 2021	0%	+0%	$13,000	647	+647	NEW	$20.09	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.